
Join to view full profile
16 Emerald RoadRobbinsville, NJ 08691
Phone+1 212-434-2000
Dr. Abdelmessieh is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Main Line Health System/Lankenau Medical CenterFellowship, Hematology and Medical Oncology, 2014 - 2017
Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalResidency, Internal Medicine, 2011 - 2014
Touro University CaliforniaClass of 2011
Certifications & Licensure
DE State License 2018 - 2027
NJ State License 2023 - 2027
PA State License 2014 - 2026
NY State License 2017 - 2019
Publications & Presentations
PubMed
- NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026.Aaron T Gerds, Jason Gotlib, Peter Abdelmessieh, Haris Ali, Mariana Castells
Journal of the National Comprehensive Cancer Network. 2026-07-01 - Synchronous presentation of pH+ B cell acute lymphoblastic leukemia and chronic lymphocytic leukemia treated with blinatumomab.Christina Darwish, Don A Baldwin, Peter Abdelmessieh
Leukemia Research Reports. 2026-01-01 - 50 citationsAcute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.Bijal Shah, Ryan J Mattison, Ramzi Abboud, Peter Abdelmessieh, Ibrahim Aldoss
Journal of the National Comprehensive Cancer Network. 2024-10-01
Press Mentions
Targeted Agent Improves Survival in FLT3-Positive Acute Myeloid LeukemiaDecember 17th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









